ITRM940396A0 - Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee - Google Patents

Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee

Info

Publication number
ITRM940396A0
ITRM940396A0 ITRM940396A ITRM940396A ITRM940396A0 IT RM940396 A0 ITRM940396 A0 IT RM940396A0 IT RM940396 A ITRM940396 A IT RM940396A IT RM940396 A ITRM940396 A IT RM940396A IT RM940396 A0 ITRM940396 A0 IT RM940396A0
Authority
IT
Italy
Prior art keywords
contain
treatment
pharmaceutical compositions
skin diseases
carnitine salt
Prior art date
Application number
ITRM940396A
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Original Assignee
Avantgarde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde filed Critical Avantgarde
Publication of ITRM940396A0 publication Critical patent/ITRM940396A0/it
Priority to ITRM940396A priority Critical patent/IT1272290B/it
Priority to EP95830209A priority patent/EP0688761A2/en
Priority to CA002150407A priority patent/CA2150407A1/en
Priority to KR1019950014607A priority patent/KR960000855A/ko
Priority to US08/473,208 priority patent/US5591450A/en
Priority to DE69502147T priority patent/DE69502147T2/de
Priority to EP95109027A priority patent/EP0697397B1/en
Priority to AT95109027T priority patent/ATE165338T1/de
Priority to ES95109027T priority patent/ES2116651T3/es
Priority to PH50702A priority patent/PH31606A/en
Priority to CA002152005A priority patent/CA2152005A1/en
Priority to KR1019950015962A priority patent/KR960000217A/ko
Priority to JP7151457A priority patent/JPH0827081A/ja
Priority to ZA955025A priority patent/ZA955025B/xx
Priority to ZA955024A priority patent/ZA955024B/xx
Priority to JP7153148A priority patent/JPH0826984A/ja
Priority to TW084106325A priority patent/TW300881B/zh
Publication of ITRM940396A1 publication Critical patent/ITRM940396A1/it
Application granted granted Critical
Publication of IT1272290B publication Critical patent/IT1272290B/it
Priority to HK98104024A priority patent/HK1004918A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
ITRM940396A 1994-06-20 1994-06-20 Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee IT1272290B (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
ITRM940396A IT1272290B (it) 1994-06-20 1994-06-20 Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
EP95830209A EP0688761A2 (en) 1994-06-20 1995-05-18 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
CA002150407A CA2150407A1 (en) 1994-06-20 1995-05-29 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
KR1019950014607A KR960000855A (ko) 1994-06-20 1995-06-02 L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
US08/473,208 US5591450A (en) 1994-06-20 1995-06-07 L-carnitine salt and compositions containing same
ES95109027T ES2116651T3 (es) 1994-06-20 1995-06-12 Sal de l-carnitina y composiciones que la contienen.
EP95109027A EP0697397B1 (en) 1994-06-20 1995-06-12 L-carnitine salt and compositions containing same
AT95109027T ATE165338T1 (de) 1994-06-20 1995-06-12 L-carnitin salz und dieses enthaltende zusammensetzungen
DE69502147T DE69502147T2 (de) 1994-06-20 1995-06-12 L-Carnitin Salz und dieses enthaltende Zusammensetzungen
PH50702A PH31606A (en) 1994-06-20 1995-06-13 L-carnitine salt and compositions containing them.
CA002152005A CA2152005A1 (en) 1994-06-20 1995-06-16 L-carnitine salt and compositions containing same
KR1019950015962A KR960000217A (ko) 1994-06-20 1995-06-16 L- 카르니틴염과 이를 함유한 조성물
JP7151457A JPH0827081A (ja) 1994-06-20 1995-06-19 Ｌ−カルニチン塩および化粧用および皮膚病処置用医薬組成物
ZA955025A ZA955025B (en) 1994-06-20 1995-06-19 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatose
ZA955024A ZA955024B (en) 1994-06-20 1995-06-19 L-carnitine salt and compositions containing same
JP7153148A JPH0826984A (ja) 1994-06-20 1995-06-20 Ｌ−カルニチン塩を含む組成物
TW084106325A TW300881B (it) 1994-06-20 1995-06-20
HK98104024A HK1004918A1 (en) 1994-06-20 1998-05-09 L-carnitine salt and compositions containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940396A IT1272290B (it) 1994-06-20 1994-06-20 Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee

Publications (3)

Publication Number Publication Date
ITRM940396A0 true ITRM940396A0 (it) 1994-06-20
ITRM940396A1 ITRM940396A1 (it) 1995-12-20
IT1272290B IT1272290B (it) 1997-06-16

Family

ID=11402602

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940396A IT1272290B (it) 1994-06-20 1994-06-20 Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee

Country Status (13)

Country Link
US (1) US5591450A (it)
EP (2) EP0688761A2 (it)
JP (2) JPH0827081A (it)
KR (2) KR960000855A (it)
AT (1) ATE165338T1 (it)
CA (2) CA2150407A1 (it)
DE (1) DE69502147T2 (it)
ES (1) ES2116651T3 (it)
HK (1) HK1004918A1 (it)
IT (1) IT1272290B (it)
PH (1) PH31606A (it)
TW (1) TW300881B (it)
ZA (2) ZA955024B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1289974B1 (it) * 1997-02-25 1998-10-19 Aldo Fassi Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
DK0951909T4 (da) 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
KR20000050756A (ko) * 1999-01-14 2000-08-05 연규 핀 귀걸이의 제조방법과 그 제품의 구조
US6090849A (en) * 1999-03-23 2000-07-18 The Board Of Regents For Oklahoma State University Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry
ITRM20010364A1 (it) * 2001-06-25 2002-12-27 Biosalts Srl Ascorbil derivati di carnitine e composizioni cosmetiche contenenti tali derivati.
EP1610760A4 (en) * 2003-03-28 2008-01-09 Lonza Ag TOPICAL COMPOSITIONS OF L-CARNITINE
JP4539096B2 (ja) * 2004-01-16 2010-09-08 日油株式会社 油性成分被覆ｌ−カルニチン塩粉末およびその用途
CN1322860C (zh) * 2004-08-31 2007-06-27 北京正大绿洲医药科技有限公司 左旋肉碱滴丸及其制备方法
US7572832B2 (en) * 2007-03-19 2009-08-11 Biolink Life Sciences, Inc. Non-hygroscopic L-carnitine salts
KR101633846B1 (ko) 2013-11-25 2016-06-27 주식회사 엘지화학 도전성 패턴 형성용 조성물 및 도전성 패턴을 갖는 수지 구조체
US10118911B2 (en) * 2015-03-27 2018-11-06 Jiangsu Hengrui Medicine Co., Ltd. P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor
CN107216339B (zh) * 2016-03-22 2021-05-04 中国科学院上海药物研究所 一种dppiv抑制剂马来酸盐的多晶型及其制备方法
CN107216340B (zh) * 2016-03-22 2021-05-04 中国科学院上海药物研究所 一种dppiv抑制剂的盐型及其制备方法
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150688B1 (en) 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
FR2627385B3 (fr) * 1988-02-23 1991-08-23 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
US5137910A (en) * 1989-05-05 1992-08-11 C.D. Searle & Co. Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee

Also Published As

Publication number Publication date
ZA955024B (en) 1996-02-08
KR960000855A (ko) 1996-01-25
JPH0827081A (ja) 1996-01-30
JPH0826984A (ja) 1996-01-30
ES2116651T3 (es) 1998-07-16
EP0697397B1 (en) 1998-04-22
CA2150407A1 (en) 1995-12-21
IT1272290B (it) 1997-06-16
EP0688761A3 (it) 1996-01-17
EP0697397A1 (en) 1996-02-21
HK1004918A1 (en) 1998-12-11
US5591450A (en) 1997-01-07
ITRM940396A1 (it) 1995-12-20
ZA955025B (en) 1996-02-08
DE69502147T2 (de) 1998-08-13
ATE165338T1 (de) 1998-05-15
DE69502147D1 (de) 1998-05-28
KR960000217A (ko) 1996-01-25
TW300881B (it) 1997-03-21
PH31606A (en) 1998-11-03
EP0688761A2 (en) 1995-12-27
CA2152005A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
ITRM940396A0 (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
ITRM940570A0 (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
NO994014L (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
IT1293934B1 (it) Chiodo endomidollare per il trattamento delle fratture dell'anca
FI910413A7 (fi) Tooppiset valmisteet ihmisen kynsien hoitamiseksi
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM940571A0 (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
BR9710376A (pt) Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
PT1017388E (pt) Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca
ITMI911853A0 (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
FI952953L (fi) Aineita metabolisten luustosairauksien hoitamiseen
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
ITRM940854A0 (it) Apparecchiatura integrata per il trattamento delle acque destinate al consumo umano
ITMI910656A0 (it) Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1293464B1 (it) Apparecchio elettromedicale per la cura di patologie infiammatorie acute

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970517